This inventor holds 1 USPTO granted patent. Top assignee: Mitotech Sa. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Natalya V Sumbatyan: Innovator in Pharmaceutical Science
Introduction
Natalya V Sumbatyan is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative substances that target mitochondrial health.
Latest Patents
Sumbatyan holds a patent for pharmaceutical substances based on mitochondria-addressed antioxidants. The patent details purified pharmaceutical preparations comprising oxidized SkQ1, ensuring that no individual impurity exceeds 1.5%, the total impurity content does not exceed 4.0%, and the content of reduced SkQ1 is not greater than 10%. This innovative approach highlights her commitment to advancing medical treatments.
Career Highlights
Sumbatyan is associated with Mitotech SA, a company focused on developing mitochondrial-targeted therapies. Her work has positioned her as a key figure in the pharmaceutical industry, contributing to the understanding and treatment of various health conditions.
Collaborations
Throughout her career, Sumbatyan has collaborated with notable scientists, including Maxim Vladimirovich Skulachev and Vladimir Petrovich Skulachev. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Natalya V Sumbatyan's innovative work in pharmaceutical science, particularly her patent on mitochondrial antioxidants, showcases her dedication to improving health outcomes. Her contributions continue to influence the industry and inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile